← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2014Last known activity
Sep 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT06873087Sponsor investigatorPhase 4Sep 1, 2023
- NCT06873087Lead sponsorPhase 4Sep 1, 2023
- NCT04411433CollaboratorPhase 3May 8, 2020
- NCT03051308Lead sponsorN/AMar 1, 2017
- NCT03051308Reponsible party - principal investigatorN/AMar 1, 2017
- NCT02241811Lead sponsorPhase 1Sep 1, 2014
- NCT02241811Reponsible party - principal investigatorPhase 1Sep 1, 2014
Details
- Last known activity
- Sep 1, 2023